Приказ основних података о документу

dc.creatorMirkov, Ivana
dc.creatorPopov Aleksandrov, Aleksandra
dc.creatorNinkov, Marina
dc.creatorMileusnić, Dina
dc.creatorDemenesku, Jelena
dc.creatorZolotarevski, Lidija
dc.creatorSubota, Vesna
dc.creatorStefik, Debora
dc.creatorKataranovski, Dragan
dc.creatorKataranovski, Milena
dc.date.accessioned2022-02-21T12:21:57Z
dc.date.available2017-11-02
dc.date.issued2016
dc.identifier.issn1382-6689
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/4812
dc.description.abstractIntestinal hemorrhage characterizes effectiveness of warfarin (WF) as rodenticide and is among adverse effects of therapy in humans. Having in mind genetic variations in the effectiveness of WF in wild rats and in the doses required for therapeutic effect, strain differences in the intestinal toxicity of oral warfarin in rats were examined in this study. High WF dose (3.5 mg/l) led to mortality in Albino Oxford (AO) rats, with no lethality in Dark Agouti (DA) rats. Higher values of prothrombin time were noted at low WF dose (0.35 mg/l) in the former strain. Leukocyte infiltration in intestine noted at this dose in both strains was associated with oxidative injury and more pronounced anti-oxidative response in AO rats. Suppression of mesenteric lymph node cell proliferation and IFN-γ and IL-10 production in AO rats and lack of these effects in DA rats, represent different strategies to protect vulnerable intestine from harmful immune responses.sr
dc.language.isoensr
dc.publisherAmsterdam, Holland:Elsevier B.V.sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173039/RS//sr
dc.relation.isversionofhttps://radar.ibiss.bg.ac.rs/handle/123456789/4813
dc.rightsembargoedAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceEnvironmental Toxicology and Pharmacologysr
dc.subjectOral warfarin administrationsr
dc.subjectAlbino Oxford (AO) and Dark agouti (DA) ratssr
dc.subjectIntestinal injurysr
dc.subjectMesenteric lymph nodessr
dc.titleStrain differences in intestinal toxicity of warfarin in ratssr
dc.typearticlesr
dc.rights.licenseBY-NC-NDsr
dc.rights.holder© 2016 Elsevier B.V.sr
dc.citation.volume48
dc.description.noteThis is the peer reviewed version of the following article: Mirkov I, Popov Aleksandrov A, Ninkov M, Mileusnic D, Demenesku J, Zolotarevski L, Subota V, Stefik D, Kataranovski D, Kataranovski M. Strain differences in intestinal toxicity of warfarin in rats. Environ Toxicol Pharmacol. 2016;48:175–82. [https://doi.org/10.1016/j.etap.2016.10.019]
dc.identifier.doi10.1016/j.etap.2016.10.019
dc.identifier.pmid27816002
dc.identifier.scopus2-s2.0-84993949501
dc.identifier.wos000390517200022
dc.citation.apaMirkov, I., Popov Aleksandrov, A., Ninkov, M., Mileusnic, D., Demenesku, J., Zolotarevski, L., et al. (2016). Strain differences in intestinal toxicity of warfarin in rats. Environmental Toxicology and Pharmacology, 48, 175–182.
dc.citation.vancouverMirkov I, Popov Aleksandrov A, Ninkov M, Mileusnic D, Demenesku J, Zolotarevski L, Subota V, Stefik D, Kataranovski D, Kataranovski M. Strain differences in intestinal toxicity of warfarin in rats. Environ Toxicol Pharmacol. 2016;48:175–82.
dc.citation.spage175
dc.citation.epage182
dc.type.versionacceptedVersionsr
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/10026/bitstream_10026.pdf
dc.citation.rankM22


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу